The world's biggest retailer, Wal-Mart, has announced a pilot program to provide assistance to US employers on managing the processing and payment of prescription drug claims. Lee Scott, the retail giant's chief executive, was speaking at the firm's annual general meeting in Kansas City, Missouri.
Although details of the Wal-Mart scheme have not yet been made public, Mr Scott said he believes that savings of over $100.0 million would be achievable for companies signing up to the project. The Wall Street Journal described the project as an indication that the retail behemoth is planning to enter the pharmacy benefit management sector.
Since the introduction of the Medicare Part D prescription drug benefit for seniors, Wal-Mart has introduced a number of marketing schemes to promote its pharmacy services, including on-line prescription ordering and a $4 per month price tag for a number of generic drugs (Marketletters passim). Wal-Mart's moves may also reflect a desire to improve its reputation as an employer with poor employee health care benefits.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze